Literature DB >> 17728103

14-3-3epsilon inhibits MK5-mediated cell migration by disrupting F-actin polymerization.

Heejae Tak1, Eunsun Jang, Seung Beom Kim, Jinhwi Park, Jinkyu Suk, Yoo Sik Yoon, Jeong Keun Ahn, Jeung-Hoon Lee, Cheol O Joe.   

Abstract

The signal pathway by which 14-3-3epsilon inhibits cell migration induced by MAPK-activated protein kinase 5 (MK5) was investigated in cultured HeLa cells. Both in vivo and in vitro analyses have revealed that 14-3-3epsilon interacts with MK5. 14-3-3epsilon bound to MK5 inhibits the phosphorylation of HSP27, a known substrate of MK5. Disturbance of actin cytoskeleton organization by 14-3-3epsilon was shown in transfected cells transiently expressing 14-3-3epsilon as well as established cells stably expressing 14-3-3epsilon. Moreover, overexpression of 14-3-3epsilon resulted in the inhibition of cell migration induced by MK5 overexpression or TNFalpha treatment. Our results suggest that 14-3-3epsilon bound to MK5 inhibits cell migration by inhibiting the phosphorylation of HSP27 whose phosphorylation regulates F-actin polymerization, actin cytoskeleton organization and subsequent actinfilament dynamics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728103     DOI: 10.1016/j.cellsig.2007.07.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  34 in total

1.  The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor.

Authors:  Sergiy Kostenko; Mahmud Tareq Hassan Khan; Ingebrigt Sylte; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

2.  Septin 8 is an interaction partner and in vitro substrate of MK5.

Authors:  Alexey Shiryaev; Sergiy Kostenko; Gianina Dumitriu; Ugo Moens
Journal:  World J Biol Chem       Date:  2012-05-26

3.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.

Authors:  Nadine Stöhr; Marcel Köhn; Marcell Lederer; Markus Glass; Claudia Reinke; Robert H Singer; Stefan Hüttelmaier
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

4.  Proteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionine.

Authors:  Paul C Schröder; Joaquín Fernández-Irigoyen; Emilie Bigaud; Antonio Serna; Rubén Renández-Alcoceba; Shelly C Lu; José M Mato; Jesús Prieto; Fernando J Corrales
Journal:  J Proteomics       Date:  2012-01-16       Impact factor: 4.044

5.  Cross-Phosphorylation and Interaction between Src/FAK and MAPKAP5/PRAK in Early Focal Adhesions Controls Cell Motility.

Authors:  Sheila Figel Dwyer; Irwin H Gelman
Journal:  J Cancer Biol Res       Date:  2014-05-14

6.  Physiological roles of mitogen-activated-protein-kinase-activated p38-regulated/activated protein kinase.

Authors:  Sergiy Kostenko; Gianina Dumitriu; Kari Jenssen Lægreid; Ugo Moens
Journal:  World J Biol Chem       Date:  2011-05-26

7.  ERK3 promotes endothelial cell functions by upregulating SRC-3/SP1-mediated VEGFR2 expression.

Authors:  Wei Wang; Ka Bian; Sreeram Vallabhaneni; Bin Zhang; Ray-Chang Wu; Bert W O'Malley; Weiwen Long
Journal:  J Cell Physiol       Date:  2014-10       Impact factor: 6.384

8.  Gene expression changes during caste-specific neuronal development in the damp-wood termite Hodotermopsis sjostedti.

Authors:  Yuki Ishikawa; Yasukazu Okada; Asano Ishikawa; Hitoshi Miyakawa; Shigeyuki Koshikawa; Toru Miura
Journal:  BMC Genomics       Date:  2010-05-20       Impact factor: 3.969

9.  Heat shock protein 27 expression is inversely correlated with atrophic gastritis and intraepithelial neoplasia.

Authors:  Yoshiaki Nagata; Masatoshi Kudo; Tomoyuki Nagai; Tomohiro Watanabe; Masanori Kawasaki; Yutaka Asakuma; Satoru Hagiwara; Naoshi Nishida; Shigenaga Matsui; Hiroshi Kashida; Toshiharu Sakurai
Journal:  Dig Dis Sci       Date:  2012-08-11       Impact factor: 3.199

10.  Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement.

Authors:  C S Foster; A R Dodson; L Ambroisine; G Fisher; H Møller; J Clark; G Attard; J De-Bono; P Scardino; V E Reuter; C S Cooper; D M Berney; J Cuzick
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.